Many of the supplements he mentions havent been thoroughly researched
These compounds belong to a class called growth hormone-releasing peptides (GHRPs), which directly activate receptors in the brain that trigger the pituitary gland to release natural growth hormone (GH)
Heres what you need to know: Standard Dose: 250-500 mcg (0.25-0.5 mg) once daily via subcutaneous injection Clinical Range: Research protocols tested 250 mcg to 1 mg daily with no additional benefit above 1 mg Timing: Morning administration in completely fasted state for optimal lipolytic effect Administration: Subcutaneous injection into abdominal fat region Cycle Length: Typically 12-24 weeks based on metabolic goals and physician guidance Reconstitution: Mixed with bacteriostatic water
found a concentration seven-fold higher in RBC than in whole blood
A., Befort, K., & Kieffer, B

Key features include: 99% purity, confirmed by HPLC and mass spectrometry for analytical accuracy and research reproducibility Pentapeptide structurewith non-proteinogenic residues (Aib and D-amino acids) conferring exceptional metabolic stability and resistance to non-specific proteolytic degradation High receptor selectivitydemonstrating minimal activity on non-target pituitary hormones including ACTH, cortisol, prolactin, FSH, LH, and TSHdistinguishing it from less selective growth hormone secretagogues Potent GHS-R1a agonist activitywith ED = 2.3 nmol/kg in conscious animal models, comparable to GHRP-6 efficacy but with enhanced selectivity Lyophilized powder formatproviding extended shelf-life stability of up to 24 months when stored appropriately, with minimal degradation under recommended cold-storage conditions Widely utilized as a pharmacological tool compoundfor structure-activity relationship (SAR) investigations and receptor-ligand selectivity studies For laboratory research use only These properties support its use as ipamorelin for research across receptor pharmacology, endocrine signaling, and growth hormone axis investigations
